These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
☒
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
☐
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
|
|
|
|
|
|
Nevada
|
|
23-3023677
|
|
(State or Other Jurisdiction of
Incorporation or Organization)
|
|
(IRS Employer
Identification No.)
|
|
75 S. Clinton Avenue Rochester, NY
(Address of Principal Executive Offices)
|
14604
(Zip Code)
|
|
Large accelerated filer
|
|
☐
|
|
Accelerated filer
|
|
☐
|
|
|
|
|
|
|||
|
Non-accelerated filer
|
|
☐
(Do not check if a smaller reporting company)
|
|
Smaller reporting company
|
|
☒
|
|
|
|
|
Emerging Growth
Company |
|
☐
|
|
|
PART I - FINANCIAL INFORMATION
|
||
|
|
|
|
|
ITEM 1.
|
Financial Statements
|
|
|
4
|
||
|
5
|
||
|
Condensed Statement of Changes in Stockholders' Deficit (Unaudited)
|
|
|
|
6
|
||
|
7
|
||
|
ITEM 2.
|
16
|
|
|
ITEM 3.
|
20
|
|
|
ITEM 4.
|
20
|
|
|
|
|
|
|
PART II - OTHER INFORMATION
|
||
|
ITEM 1.
|
20
|
|
|
ITEM 1A.
|
20
|
|
|
ITEM 2.
|
20
|
|
|
ITEM 3.
|
20
|
|
|
ITEM 4.
|
21
|
|
|
ITEM 5.
|
21
|
|
|
ITEM 6.
|
21
|
|
|
22
|
||
|
VerifyMe, Inc.
|
|
|
|
|
|
As of
|
|||||||
|
|
March 31, 2018
|
December 31, 2017
|
||||||
|
|
(Unaudited)
|
|||||||
|
|
||||||||
|
ASSETS
|
||||||||
|
|
||||||||
|
CURRENT ASSETS
|
||||||||
|
Cash and cash equivalents
|
$
|
2,341,401
|
$
|
693,001
|
||||
|
Prepaid expenses and other current assets
|
31,234
|
18,668
|
||||||
|
Inventory
|
9,768
|
-
|
||||||
|
TOTAL CURRENT ASSETS
|
2,382,403
|
711,669
|
||||||
|
|
||||||||
|
OTHER ASSETS
|
||||||||
|
Patents and Trademarks, net of accumulated amortization of
|
||||||||
|
$242,365 and $237,331 as of March 31, 2018 and December 31, 2017
|
187,298
|
191,507
|
||||||
|
|
||||||||
|
TOTAL ASSETS
|
$
|
2,569,701
|
$
|
903,176
|
||||
|
|
||||||||
|
LIABILITIES AND STOCKHOLDERS' DEFICIT
|
||||||||
|
|
||||||||
|
CURRENT LIABILITIES
|
||||||||
|
Accounts payable and accrued expenses
|
$
|
513,191
|
$
|
923,202
|
||||
|
Notes payable
|
50,000
|
50,000
|
||||||
|
Common Stock payable
|
-
|
122,478
|
||||||
|
TOTAL CURRENT LIABILITIES
|
563,191
|
1,095,680
|
||||||
|
|
||||||||
|
STOCKHOLDERS' EQUITY (DEFICIT)
|
||||||||
|
Series A Convertible Preferred Stock, $.001 par value, 37,564,767 shares
|
||||||||
|
authorized; 304,778 shares issued and outstanding as of March 31, 2018 and
|
||||||||
|
324,778 shares issued and outstanding as of December 31, 2017
|
305
|
325
|
||||||
|
|
||||||||
|
Series B Convertible Preferred Stock, $.001 par value; 85 shares
|
||||||||
|
authorized; 0.85 shares issued and outstanding as of March 31, 2018 and
|
||||||||
|
0.92 shares issued and outstanding as of December 31, 2017
|
-
|
-
|
||||||
|
|
||||||||
|
Common stock of $.001 par value; 675,000,000 authorized; 92,945,925 and
53,873,872 issued, 92,595,385 and 53,523,332 shares outstanding as of March 31, 2018 and December 31, 2017 |
92,944
|
53,522
|
||||||
|
|
||||||||
|
Additional paid in capital
|
59,481,371
|
56,198,126
|
||||||
|
|
||||||||
|
Treasury stock as cost (350,540 shares at March 31, 2018 and December 31,
2017) |
(113,389
|
)
|
(113,389
|
)
|
||||
|
|
||||||||
|
Accumulated deficit
|
(57,454,721
|
)
|
(56,331,088
|
)
|
||||
|
|
||||||||
|
STOCKHOLDERS' EQUITY (DEFICIT)
|
2,006,510
|
(192,504
|
)
|
|||||
|
|
||||||||
|
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
|
$
|
2,569,701
|
$
|
903,176
|
||||
|
VerifyMe, Inc.
|
|
(Unaudited)
|
|
|
Three months ended
|
|||||||
|
|
March 31, 2018
|
March 31, 2017
|
||||||
|
|
||||||||
|
OPERATING EXPENSES
|
||||||||
|
General and administrative (a)
|
495,574
|
142,061
|
||||||
|
Legal and accounting
|
133,704
|
9,044
|
||||||
|
Payroll expenses (a)
|
92,051
|
22,810
|
||||||
|
Research and development
|
12,196
|
8,669
|
||||||
|
Sales and marketing
|
8,042
|
5,921
|
||||||
|
Total Operating expenses
|
741,567
|
188,505
|
||||||
|
|
||||||||
|
LOSS BEFORE OTHER INCOME (EXPENSE)
|
(741,567
|
)
|
(188,505
|
)
|
||||
|
|
||||||||
|
OTHER (EXPENSE) INCOME
|
||||||||
|
Interest expenses, net
|
(791
|
)
|
(66,544
|
)
|
||||
|
Settlement agreement with shareholders
|
(779,000
|
)
|
-
|
|||||
|
Gain on accounts payable forgiveness
|
397,725
|
-
|
||||||
|
Change in fair value of warrants
|
-
|
(28,256
|
)
|
|||||
|
Change in fair value of embedded derivative liability
|
-
|
(21,282
|
)
|
|||||
|
|
(382,066
|
)
|
(116,082
|
)
|
||||
|
|
||||||||
|
NET LOSS
|
$
|
(1,123,633
|
)
|
$
|
(304,587
|
)
|
||
|
|
||||||||
|
LOSS PER SHARE
|
||||||||
|
BASIC
|
$
|
(0.01
|
)
|
$
|
(0.04
|
)
|
||
|
DILUTED
|
$
|
(0.01
|
)
|
$
|
(0.04
|
)
|
||
|
|
||||||||
|
WEIGHTED AVERAGE COMMON SHARE OUTSTANDING
|
||||||||
|
BASIC
|
76,278,102
|
8,397,976
|
||||||
|
DILUTED
|
76,278,102
|
8,397,976
|
||||||
| (a) |
Includes share related payments of $289,903 and $51,597 for the three months ended March 31, 2018 and 2017, respectively.
|
|
VerifyMe, Inc.
|
|
(Unaudited)
|
|
|
Three Months Ended
|
|||||||
|
|
March 31, 2018
|
March 31, 2017
|
||||||
|
CASH FLOWS FROM OPERATING ACTIVITIES
|
||||||||
|
Net loss
|
$
|
(1,123,633
|
)
|
$
|
(304,587
|
)
|
||
|
Adjustments to reconcile net loss to net cash used in
|
||||||||
|
operating activities:
|
||||||||
|
Stock based compensation
|
32,644
|
-
|
||||||
|
Fair value of options and warrants issued in exchange for services
|
205,969
|
51,597
|
||||||
|
Fair value of restricted stock and restricted stock units issued in exchange for
services |
51,290
|
-
|
||||||
|
Gain on accounts payable forgiveness
|
(397,725
|
)
|
-
|
|||||
|
Share-based payment for settlement agreement with shareholders
|
279,000
|
-
|
||||||
|
Accretion of discount on notes payable
|
-
|
64,529
|
||||||
|
Change in fair value of warrant liability
|
-
|
28,256
|
||||||
|
Change in fair value of embedded derivative liability
|
-
|
21,282
|
||||||
|
Amortization and depreciation
|
5,034
|
(2,212
|
)
|
|||||
|
Changes in operating assets and liabilities:
|
||||||||
|
Inventory
|
(9,768
|
)
|
1,535
|
|||||
|
Prepaid expenses and other current assets
|
(12,566
|
)
|
300
|
|||||
|
Accounts payable and accrued expenses
|
(12,286
|
)
|
(5,122
|
)
|
||||
|
Net cash used in operating activities
|
(982,041
|
)
|
(144,422
|
)
|
||||
|
|
||||||||
|
CASH FLOWS FROM INVESTING ACTIVITIES
|
||||||||
|
Purchase of Patents
|
(825
|
)
|
-
|
|||||
|
Net cash used in investing activities
|
(825
|
)
|
-
|
|||||
|
|
||||||||
|
CASH FLOWS FROM FINANCING ACTIVITIES
|
||||||||
|
Proceeds from issuance of related party notes payable
|
-
|
145,000
|
||||||
|
Proceeds from exercise of warrants
|
1,476,489
|
-
|
||||||
|
Proceeds from sale of common stock
|
1,154,777
|
-
|
||||||
|
Net cash provided by financing activities
|
2,631,266
|
145,000
|
||||||
|
|
||||||||
|
NET INCREASE IN CASH AND
|
||||||||
|
CASH EQUIVALENTS
|
1,648,400
|
578
|
||||||
|
CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD
|
693,001
|
22,644
|
||||||
|
|
||||||||
|
CASH AND CASH EQUIVALENTS - END OF PERIOD
|
$
|
2,341,401
|
$
|
23,222
|
||||
|
|
||||||||
|
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
|
||||||||
|
Cash paid during the year for:
|
||||||||
|
Interest
|
$
|
-
|
$
|
-
|
||||
|
Income taxes
|
$
|
-
|
$
|
-
|
||||
|
|
||||||||
|
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES
|
||||||||
|
|
||||||||
|
Series A Convertible Preferred Stock converted to common stock
|
$
|
400
|
$
|
660
|
||||
|
Series B Convertible Preferred Stock converted to common stock
|
$
|
599
|
$
|
-
|
||||
|
Cashless Exercise of Stock Options
|
$
|
4,028
|
$
|
-
|
||||
|
Common Stock and Warrants Issued for Common Stock Payable
|
$
|
122,478
|
$
|
-
|
||||
|
Warrants issued as discount to notes payable
|
$
|
-
|
$
|
119,651
|
||||
|
|
March 31,
2018
|
December 31,
2017
|
||||||
|
Series A notes payable; interest at 8% per annum; principal and
accrued interest due at maturity in October 2011 (past due) |
$
|
50,000
|
$
|
50,000
|
||||
|
Net
|
50,000
|
50,000
|
||||||
|
Less: current portion
|
(50,000
|
)
|
(50,000
|
)
|
||||
|
Balance
|
$
|
-
|
$
|
-
|
||||
|
|
||||
|
Risk Free Interest Rate
|
2.39
|
%
|
||
|
Expected Volatility
|
201.48
|
%
|
||
|
Expected Life (in years)
|
5.0
|
|||
|
Dividend Yield
|
0
|
%
|
||
|
Weighted average estimated fair value of
|
||||
|
options during the period
|
$
|
0.18
|
||
|
Options Outstanding
|
||||||||||||||||
|
Weighted -
|
||||||||||||||||
|
Average
|
||||||||||||||||
|
Remaining
|
Aggregate
|
|||||||||||||||
|
Weighted-
|
Contractual
|
Intrinsic
|
||||||||||||||
|
Number of
|
Average
|
Term
|
Value
|
|||||||||||||
|
Shares
|
Exercise Price
|
(in years)
|
(1)
|
|||||||||||||
|
|
||||||||||||||||
|
Balance as of December 31, 2017
|
22,013,529
|
$
|
0.11
|
|||||||||||||
|
|
||||||||||||||||
|
Granted
|
1,000,000
|
0.21
|
||||||||||||||
|
Exercised
|
(5,000,000
|
)
|
0.07
|
|||||||||||||
|
Balance March 31, 2018
|
18,013,529
|
$
|
0.13
|
|||||||||||||
|
|
||||||||||||||||
|
Exercisable at March 31, 2018
|
15,513,529
|
$
|
0.14
|
4.6
|
$
|
2,795,335
|
||||||||||
|
|
||||||||||||||||
| (1) |
The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the quoted price of the Company’s common stock for options that were in-the-money at each respective period. As of March 31, 2018, the aggregate intrinsic value of options exercised under the Company’s stock option plans was $2,795,335.
|
|
|
Unvested Options
|
|||||||
|
|
Weighted -
|
|||||||
|
|
Average
|
|||||||
|
|
Grant
|
|||||||
|
|
Number of Unvested
|
Date Exercise Price
|
||||||
|
|
Options
|
|||||||
|
Balance December 31, 2017
|
2,666,666
|
$
|
0.06
|
|||||
|
|
||||||||
|
Granted
|
1,000,000
|
0.21
|
||||||
|
|
||||||||
|
Vested
|
(1,166,666
|
)
|
0.11
|
|||||
|
|
||||||||
|
Balance March 31, 2018
|
2,500,000
|
$
|
0.10
|
|||||
|
|
Warrants Outstanding
|
|||||||||||||||
|
|
Number of
Shares |
Weighted-
Average
Exercise
Price
|
Weighted -
Average
Remaining
Contractual
Term
in years)
|
Aggregate
Intrinsic
Value
(in 000's)
(1) |
||||||||||||
|
Balance, December 31, 2017
|
32,292,580
|
$
|
0.30
|
|
||||||||||||
|
Granted
|
18,262,994
|
0.15
|
|
|||||||||||||
|
Exercised
|
(14,712,459
|
)
|
0.10
|
|||||||||||||
|
Cancelled/Forfeited
|
(4,950,000
|
)
|
0.40
|
|
||||||||||||
|
|
|
|||||||||||||||
|
Balance, March 31, 2018
|
30,893,116
|
$
|
0.22
|
4.4
|
|
|||||||||||
|
|
|
|||||||||||||||
|
Exercisable at March 31, 2018
|
30,893,116
|
$
|
0.22
|
4.4
|
$
|
5,515
|
||||||||||
| (1) |
The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying warrants and the closing stock price of $0.28 for our common stock on March 31, 2018.
|
|
|
Three Months Ended
March 31, |
|||||||
|
2018
|
2017
|
|||||||
|
|
||||||||
|
Net loss
|
$
|
(1,123,633
|
)
|
$
|
(304,587
|
)
|
||
|
|
||||||||
|
Interest expenses, net
|
791
|
66,544
|
||||||
|
Amortization and depreciation
|
5,034
|
(2,212
|
)
|
|||||
|
Total EBITDA (Non-GAAP)
|
(1,117,808
|
)
|
(240,255
|
)
|
||||
|
|
||||||||
|
Adjustments:
|
||||||||
|
|
||||||||
|
Stock based compensation
|
32,644
|
-
|
||||||
|
Fair value of options and warrants issued in exchange for services
|
205,969
|
51,597
|
||||||
|
Fair value of restricted stock and restricted stock units issued in exchange for services
|
51,290
|
-
|
||||||
|
Share-based payment for settlement agreement with shareholders
|
279,000
|
-
|
||||||
|
Cash payment for settlement agreement with shareholders
|
500,000
|
-
|
||||||
|
|
||||||||
|
Total Adjusted EBITDA(Loss)
|
$
|
(48,905
|
)
|
$
|
(188,658
|
)
|
||
|
|
|
Incorporated by Reference
|
Filed or
Furnished
|
||||||
|
Exhibit #
|
Exhibit Description
|
Form
|
Date
|
Number
|
Herewith
|
||||
|
3.1
|
10-Q
|
August 19, 2015
|
3.1
|
||||||
|
3.2
|
8-K
|
August 15, 2017
|
3.1
|
||||||
|
4.1
|
8-K
|
June 18, 2015
|
3.2
|
|
|||||
|
4.2
|
8-K
|
June 18, 2015
|
3.3
|
|
|||||
|
4.3
|
8-K
|
February 10, 2016
|
3.1
|
|
|||||
|
4.4
|
10-K
|
April 12, 2017
|
3.9
|
||||||
|
4.5
|
Filed
|
||||||||
|
10.1
|
10-K
|
April 16, 2018
|
10.21
|
||||||
|
10.2
|
10-K
|
April 16, 2018
|
10.28
|
||||||
|
10.3
|
10-K
|
April 16, 2018
|
10.29
|
||||||
|
10.4
|
10-K
|
April 16, 2018
|
10.30
|
||||||
|
10.5
|
10-K
|
April 16, 2018
|
10.31
|
||||||
|
10.6
|
10-K
|
April 16, 2018
|
10.32
|
||||||
|
10.19
|
10-K
|
April 16, 2018
|
10.19
|
||||||
|
31.1
|
|
|
|
Filed
|
|||||
|
31.2
|
|
|
|
Filed
|
|||||
|
32.1
|
|
|
|
Furnished**
|
|||||
|
101.INS
|
XBRL Instance Document
|
|
|
|
Filed
|
||||
|
101.SCH
|
XBRL Taxonomy Extension Schema Document
|
|
|
|
Filed
|
||||
|
101.CAL
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
|
Filed
|
||||
|
101.DEF
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
|
|
Filed
|
||||
|
101.LAB
|
XBRL Taxonomy Extension Label Linkbase Document
|
|
|
|
Filed
|
||||
|
101.PRE
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|
|
|
Filed
|
||||
|
*
|
Management contract or compensatory plan or arrangement.
|
|
|
**
|
This exhibit is being furnished rather than filed and shall not be deemed incorporated by reference into any filing, in accordance with Item 601 of Regulation S-K.
|
|
|
|
VERIFYME, INC.
|
|
|
|
|
|
|
Date: May 15, 2018
Date: May 15, 2018
|
By: /S/ Patrick White
Patrick White
Chief Executive Officer
By/S/ James Cardwell
James Cardwell
Chief Financial Officer
|
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|